5-Amino-1MQ Injection Dosage Per Day: What the Research Actually Shows

There is no established 5-amino-1MQ injection dosage per day for humans. 5-Amino-1MQ is a research chemical that has never been evaluated in a published human clinical trial, so every number circulating online is either extrapolated from mouse studies or copied from anonymous self-experimentation reports. The sections below explain where those figures come from, how injection and oral amounts compare, and why none of them should be treated as a safe protocol.

What Is 5-Amino-1MQ?

5-Amino-1MQ is a small synthetic molecule, not a peptide. Its full chemical name is 5-amino-1-methylquinolinium, and its main researched mechanism is inhibition of nicotinamide N-methyltransferase (NNMT), an enzyme involved in fat and energy metabolism.

Because the molecule carries a permanent positive charge, it crosses cell membranes readily and has been shown to be orally bioavailable in rodents. That combination is unusual, and it is a large part of why the compound attracted attention in metabolic research.

5-Amino-1MQ is not FDA-approved for human use in the United States. It is sold as a "research chemical" and labeled for laboratory use only, which means it is not manufactured under pharmaceutical quality standards.

Is There an Established 5-Amino-1MQ Injection Dosage Per Day?

No. No published human study has established a safe, effective, or even a measured 5-amino-1MQ injection dosage per day.

Researchers have no human data on the compound's half-life, its clearance rate, how much of an injected amount reaches target tissues, or the amount at which side effects begin. Without that information, any specific number is a guess.

The only controlled dosing information comes from mice. Those studies used daily administration and reported metabolic improvements, but animal amounts are calculated per kilogram of body weight and do not convert directly into a human dose.

What Amounts Do People Actually Report?

Public discussion clusters around the vial sizes suppliers sell: 5 mg, 10 mg, and 50 mg. Anyone searching for a 5-amino-1mq dosage per day will mostly find self-reported ranges rather than clinical guidance.

Route	Anecdotal amounts discussed	Reported frequency	Key caveats
Subcutaneous injection	Roughly 5–20 mg per day; a minority report up to 50 mg	Usually once daily	No human safety data; sterility and measurement errors are real risks
Oral capsule or powder	Roughly 50–150 mg per day	Once or twice daily	Larger amounts are used because absorption is inconsistent
Intramuscular injection	Similar to subcutaneous ranges	Usually once daily	No documented advantage over subcutaneous in humans

These figures summarize anecdotal reports; they are not recommendations. Self-reported logs rarely include baseline bloodwork, controlled measurements, or follow-up, and people who experience problems are less likely to post about them than people who feel fine.

Why Subcutaneous and Oral Amounts Differ

A direct comparison of 5-amino-1mq oral vs injection dosage shows a consistent pattern: injected amounts discussed online are smaller than oral amounts. Injecting a compound bypasses digestion and first-pass liver metabolism, so more of the amount reaches circulation unchanged.

That is a general pharmacological principle, not a verified finding for 5-amino-1MQ specifically, because no human absorption study exists. Orally, users report taking much larger amounts, partly because gut absorption of a charged molecule is variable and hard to predict.

Anyone researching a 5-amino-1mq subcutaneous injection dosage should understand that the route changes the risk profile as well as the amount. Sterile technique, accurate reconstitution, and precise measurement become safety issues the moment a powder is mixed for injection.

What the Animal Research Actually Shows

The most cited study on 5-amino-1MQ was published in 2018 in the journal Biochemical Pharmacology. Researchers gave the compound to diet-induced obese mice and reported reduced body weight gain, lower fat mass, and improved glucose tolerance compared with control animals.

Those results are interesting, and they are also preliminary. Mouse models of obesity frequently produce effects that do not replicate in humans, and a single research group's findings are not a clinical consensus.

Preclinical work also indicates that NNMT participates in many biological processes beyond fat metabolism, including cellular stress responses and drug metabolism. Blocking the enzyme throughout the body in humans could produce effects that no mouse study has identified.

Risks and Safety Concerns With Injectable 5-Amino-1MQ

Injectable research chemicals carry risks that oral capsules do not.

• Sterility: Research-grade powder is not guaranteed sterile or free of endotoxins, and it is not intended for injection into humans.
• Dosing errors: Reconstitution math is a common source of serious mistakes, especially with small vials.
• Unknown long-term effects: Nobody knows what chronic NNMT inhibition does in the human body over months or years.
• Injection site reactions: Redness, swelling, pain, and nodules are commonly reported with subcutaneous research chemical injections.
• Purity: Independent testing of research chemicals often finds that the labeled content does not match what is inside the vial.

5-Amino-1MQ has not been evaluated for carcinogenicity, reproductive toxicity, or drug interactions in humans. People who take prescription medication, who are pregnant or breastfeeding, or who have a diagnosed medical condition face additional unknown risk.

Legal and Quality-Control Reality

In the United States, 5-Amino-1MQ is neither an approved drug nor a legal dietary supplement ingredient. It sits in a gray area where vendors sell it for laboratory research while many buyers intend something else.

Injectables sold for research purposes are not subject to FDA manufacturing oversight, and label claims about purity and quantity are frequently unverified. Vial sizes drive much of the online conversation — searches for a 5-amino-1mq 50mg injection dosage, for example, mostly reflect what happens to be sold rather than what any study supports.

The same pattern appears across the research-chemical world. A search for cjc-1295 ipamorelin dosage per day reddit returns a similar mix of forum anecdotes, vendor blogs, and animal studies, with no human trial data to anchor it.

What to Ask a Healthcare Professional

Anyone considering 5-amino-1MQ should discuss it with a licensed healthcare professional first, and should be honest about the source and form of the product. Useful questions include:

1. Are there any human studies on this compound that I should read?
2. How could an unapproved research chemical interact with medications I already take?
3. Which symptoms would suggest I should stop and seek care?
4. Are there FDA-approved options for the goal I am trying to reach?

Clinicians can also order baseline labs and monitor for changes that self-experimentation would miss.

Bottom Line on Injectable 5-Amino-1MQ

No human trial has established a 5-amino-1MQ injection dosage per day, and no reliable conversion from mouse studies to human dosing exists. Reported amounts are anecdotes built around common vial sizes, not clinical evidence.

5-Amino-1MQ is an unapproved research chemical with unknown human safety, unknown interactions, and inconsistent product quality. Anyone considering it should treat the absence of human data as the most important piece of information available and speak with a healthcare professional before making any decision.

COMMON QUESTIONS

Frequently Asked Questions

How much 5-amino-1MQ should I inject per day?

No safe or effective human dose has ever been established for 5-amino-1MQ, because the compound has not been tested in published human trials. Anecdotal reports describe subcutaneous amounts in the range of 5 to 20 mg per day, with a smaller number of people reporting up to 50 mg, but those numbers come from self-experimentation rather than clinical data. There is no evidence-based injection protocol, and a healthcare professional should be consulted before considering any use.

Is 5-amino-1MQ FDA approved?

No. 5-Amino-1MQ is not FDA-approved for human use in the United States and is not a recognized dietary supplement ingredient. It is sold online as a research chemical labeled for laboratory use only, which means it is not held to pharmaceutical manufacturing or purity standards. Products sold for research purposes are not intended for human consumption.

Does injectable 5-amino-1MQ help with weight loss?

There is no human evidence that injectable 5-amino-1MQ causes weight loss in people. The supporting data comes from diet-induced obese mice, which lost fat mass and showed improved glucose tolerance in a 2018 study. Mouse results often fail to translate to humans, and no clinical trial has tested the compound for weight loss in people. Anyone seeking weight-loss treatment should speak with a healthcare professional about FDA-approved options.